Top Stock Reports For Walmart, Nike & Citigroup
Zacks Investment Research | Dec 02, 2019 02:10AM ET
Monday, December 2, 2019
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (NYSE:WMT), NIKE, Inc. (NKE) and Citigroup Inc. (NYSE:C). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Walmart’s shares have outperformed the Zacks Retail - Supermarkets industry year to date (+27.0% vs. +24.2%). The Zacks analyst believes that Walmart’s top line has been gaining from its focus on enhancing e-commerce and store operations. Further, the company is making efforts to improve its International unit by shifting focus to profitable countries. These factors helped Walmart retain its sturdy earnings surprise record in third-quarter fiscal 2019, wherein U.S. comps rose for the 21st straight time.
However, the company has been witnessing strained margins for a while now, due to costs associated with e-commerce and technological investments; along with a compelling pricing strategy. In fact, investment in Flipkart is expected to continue weighing on Walmart’s bottom line in fiscal 2020.
(You can )
Shares of Nike (NYSE:NKE) have gained 54.7% in the past two-year period against the Zacks Shoes and Retail Apparel industry’s rise of 48.7%. The Zacks analyst believes that despite a volatile macroeconomic and geopolitical environment, Nike expects to continue investing in key capabilities to aid digital transformation and deliver robust growth in fiscal 2020 and beyond.
First-quarter fiscal 2020 had already marked the 10th straight quarter of top-line beat for the company, with earnings beat in 29 of the last 30 quarters. But, higher SG&A expenses and tax rate, as well as adverse currency are headwinds. The company expects SG&A expenses to increase high-single digit in second-quarter fiscal 2020.
(You can )
Citigroup’s shares have outperformed the Zacks Banks - Major Regional industry year to date (+45.1% vs. +30.5%). The Zacks analyst believes that its impressive third quarter results reflected revenue strength, along with rising loan and deposit balance. Also, investment banking revenues escalated and reduced volumes and client activity levels were recorded in the quarter. Citigroup’s streamlining efforts, along with strategic investments in core business, bode well for the long term. Also, declining costs base support the bottom-line improvement.
Get The News You Want
However, pending litigation issues might keep legal expenses elevated. Further, decline in fee income is another concern for the company.
(You can )
Other noteworthy reports we are featuring today include BP p.l.c. (LON:BP), Intel Corporation (NASDAQ:INTC) and ResMed Inc. (RMD).
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
See 5 Stocks Set to Double>>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Editas focuses on developing its lead candidate EDIT-101 to treat LCA10, a rare genetic illness that causes blindness.
Per the Zacks analyst Pattern Energy's long-term power sales agreement with customers and expanding renewable assets for clean electricity generation will boost its performance.
Per the Zacks Analyst, increased contract wins from the Pentagon and other U.S. allies bolsters Teledyne's backlog.
The Zacks analyst expects the third stage of West Nile Delta Project to fetch significant cash flows to BP's portfolio.
Growth in the U.S. used-car vehicle market will buoy LKQ's North American unit.
While Ingevity faces headwind from soft industrial demand across Europe and Asia, the Capa caprolactone acquisition will drive its revenues and earnings, per the Zacks analyst.
Per the Zacks analysts, strategic initiatives to improve production efficiency and solid growth opportunities in the industrial market are benefitting Universal Forest Products.
Per the Zacks analyst, Editas focuses on developing its lead candidate EDIT-101 to treat LCA10, a rare genetic illness that causes blindness.
Per the Zacks analyst Pattern Energy's long-term power sales agreement with customers and expanding renewable assets for clean electricity generation will boost its performance.
Per the Zacks Analyst, increased contract wins from the Pentagon and other U.S. allies bolsters Teledyne's backlog.
The Zacks analyst expects the third stage of West Nile Delta Project to fetch significant cash flows to BP's portfolio.
Growth in the U.S. used-car vehicle market will buoy LKQ's North American unit.
While Ingevity faces headwind from soft industrial demand across Europe and Asia, the Capa caprolactone acquisition will drive its revenues and earnings, per the Zacks analyst.
Per the Zacks analysts, strategic initiatives to improve production efficiency and solid growth opportunities in the industrial market are benefitting Universal Forest Products.
New Upgrades/h6
The Zacks analyst is bullish about ResMed's recent collaboration deal with Cerner (NASDAQ:CERN) which has boosted its SaaS portfolio.
Per the Zacks analyst, Intel focuses on boosting its data centre business, wherein investments in FPGA and Xeon Scalable as well as the inclusion of Altera and eASIC are likely to aid top-line growth.
Per the Zacks analyst, FTI Consulting excels as a partner for global clients dealing with international arbitration issues, thus generating continued revenue growth from international operations.
The Zacks analyst is bullish about ResMed's recent collaboration deal with Cerner (NASDAQ:CERN) which has boosted its SaaS portfolio.
Per the Zacks analyst, Intel focuses on boosting its data centre business, wherein investments in FPGA and Xeon Scalable as well as the inclusion of Altera and eASIC are likely to aid top-line growth.
Per the Zacks analyst, FTI Consulting excels as a partner for global clients dealing with international arbitration issues, thus generating continued revenue growth from international operations.
New Downgrades/h6
The Zacks analyst is concerned about the softness in railcar deliveries due to sluggish demand. The company's high debt levels further add to its woes.
Per the Zacks analyst, higher losses from catastrophes affect the company's underwriting results.
Per the Zacks analyst, NETGEAR is likely to lose its cost advantage from manufacturing in low-cost countries like China due to various trade restrictions, leading to soft margins and stiff price wars.
The Zacks analyst is concerned about the softness in railcar deliveries due to sluggish demand. The company's high debt levels further add to its woes.
Per the Zacks analyst, higher losses from catastrophes affect the company's underwriting results.
Per the Zacks analyst, NETGEAR is likely to lose its cost advantage from manufacturing in low-cost countries like China due to various trade restrictions, leading to soft margins and stiff price wars.
undefined Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.